Stratistics MRC에 따르면 세계 첨단 상처 치료 및 봉합 시장은 2024년에 222억 달러를 차지하고, 2030년에는 332억 달러에 이를 것으로 예측되며, 예측 기간 중 CAGR은 6.2%로 성장할 전망입니다.
상처 치료와 봉합은 외상이나 수술에 의한 급성상처, 당뇨병성 발궤양, 욕창, 정맥성 하퇴궤양 등의 만성상처 등 복잡한 상처를 관리하고 치유를 가속화하는데 사용되는 전문적인 의료 개입과 제품입니다. 고급 드레싱 재료, 피부 대용제, 음압상처치료(NPWT), 조직 접착제, 스테이플, 봉합사 등의 상처 폐쇄 제품이 모두 포함됩니다. 이 치료제는 환자의 결과를 개선하고 치유를 촉진하며 감염을 방지합니다.
미국 정부의 추계에 의하면, 2060년까지 고령자 인구는 7,700만명을 넘습니다. 미국 전체에서는 전체 인구의 약 2%가 만성 상처를 앓고 있는 것으로 추정되고 있습니다.
만성 질환 증가
당뇨병, 비만, 심혈관 장애 등의 만성 질환 증가는 고도의 상처 치료 및 봉합 시장의 중요한 촉진요인입니다. 많은 첨단 상처 관리 솔루션 필요합니다. 이 질병에 걸리기 쉬운 고령화 인구 증가가이 동향을 더욱 가속화하고 있습니다.
고급 상처 치료 제품의 높은 가격
고도의 상처 치료 제품의 높은 가격이 시장 성장의 큰 억제요인이 되고 있습니다. 개발 도상국 및 건강 관리의 적용 범위가 제한된 지역에서는 많은 환자에게 비용이 많이 드는 경향이 있습니다. 이는 제한으로 이어질 수 있습니다.
재생 의료 진보
재생 의학의 진보는 손상된 조직과 기관의 수리, 대체 및 재생에 중점을두고 복잡한 상처 치유에 대한 유망한 해결책을 제공합니다. 혁신은 만성 및 급성 상처 치료를 위한 새로운 길을 열었습니다. 이러한 기술은 치유를 가속화하고 흉터를 줄이고 환자의 예후를 개선 할 수있는 가능성을 가지고 있습니다.
제품 리콜 및 안전에 대한 우려
제품의 결함, 부작용, 예기치 않은 합병증의 발생은 리콜로 이어질 수 있으며, 주요 기업의 평판과 소비자의 신뢰를 모두 손상시킵니다. 제조업체의 경제적 손실로 이어질 수 있습니다. 또한 의료 종사자가 보다 신중해지기 때문에 안전에 대한 우려가 신기술의 채용을 늦출 가능성도 있습니다. 시장의 성장을 둔화시킬 수 있습니다.
COVID-19의 팬데믹은 처음에는 첨단 상처 관리 및 상처 폐쇄 시장을 혼란시켜 공급망 문제나 긴급 처치 이외의 처치의 연기를 일으켰습니다. 팬데믹은 상처 치료 관리에의 원격 의료 솔루션의 채용을 가속시켜, 상처 치료 프로토콜에 있어서 감염 대책의 필요성을 강조했습니다.
예측기간 동안 드레싱 재료 분야가 최대가 될 전망
예측 기간 동안 드레싱 재료 분야가 시장 점유율을 독점할 것으로 예측됩니다. 다양한 상처의 상태에 대응할 수 있는 고도의 드레싱재의 범용성과 유효성이 그 보급에 공헌하고 있습니다. 소재와 디자인에 있어서의 기술 혁신이 진행되고 있는 것도, 이 부문의 성장을 한층 더 뒷받침하고 있습니다.
음압상처치료(NPWT) 분야는 예측기간 중 가장 높은 CAGR이 예상된다.
예측 기간 동안 음압상처치료(NPWT) 분야는 가장 높은 CAGR로 성장할 것으로 예상됩니다. NPWT 시스템은 과도한 체액을 제외합니다. 부종을 완화하고 조직 형성을 자극하는 통제 된 음압 환경을 생성하여 보다 빠른 치유를 촉진합니다. 다양한 상처를 치료할 수 있는 범용성이 이 기술의 채용 확대에 기여하고 있습니다.
예측 기간 동안 북미가 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 또한 복잡한 상처로 이어지는 경우가 많습니다. 요병이나 비만 등의 만성질환의 유병률도 북미 쪽이 높습니다. 유리한 상환 정책과 고령화 인구 증가가 시장 규모에 공헌하고 있습니다.
아시아태평양은 예측 기간 동안 가장 높은 CAGR을 달성할 것으로 예상됩니다. 만성 질환의 유병률 상승 외에도 고급 상처 치료 치료 기술에 대한 의식의 고조가 시장 확대의 원동력이 되고 있습니다. 이 지역의 의료 관광 산업의 확대도 시장 확대에 기여하고 있습니다.
According to Stratistics MRC, the Global Advanced Wound Care and Closure Market is accounted for $22.2 billion in 2024 and is expected to reach $33.2 billion by 2030, growing at a CAGR of 6.2% during the forecast period. Advanced wound care and closure are specialized medical interventions and products used to manage and speed up the healing of complex wounds, such as acute wounds from trauma or surgery, as well as chronic wounds like diabetic foot ulcers, pressure ulcers, and venous leg ulcers. Advanced dressings, skin substitutes, negative pressure wound therapy (NPWT), and closure products such as tissue adhesives, staples, and sutures are all included. These remedies seek to improve patient outcomes, promote healing, and stop infection.
According to the U.S. government estimates, by the year 2060, the elderly population will be over 77 million. Overall, in the United States approximately 2% of the total population are estimated to be affected by chronic wounds.
Rising prevalence of chronic diseases
The increasing prevalence of chronic diseases, such as diabetes, obesity, and cardiovascular disorders, is a significant driver for the advanced wound care and closure market. These conditions often lead to chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, which require advanced wound care solutions. The growing aging population, which is more susceptible to these diseases, further amplifies this trend. As the number of patients with chronic wounds rises, the demand for advanced wound care products and technologies increases, driving market growth.
High cost of advanced wound care products
The high cost of advanced wound care products poses a significant restraint to market growth. These products often incorporate sophisticated technologies and materials, resulting in higher production costs and, consequently, higher prices for end-users. The expense can be prohibitive for many patients, especially in developing countries or areas with limited healthcare coverage. The cost factor can lead to slower adoption rates and limited market penetration in certain regions.
Advancements in regenerative medicine
Advancements in regenerative medicine focus on repairing, replacing, or regenerating damaged tissues and organs, offering promising solutions for complex wound healing. Innovations in stem cell therapy, tissue engineering, and growth factors are opening new avenues for treating chronic and acute wounds. These technologies have the potential to accelerate healing, reduce scarring, and improve overall patient outcomes. As research progresses and clinical applications expand, regenerative medicine approaches are likely to become more integrated into advanced wound care protocols.
Product recalls and safety concerns
Incidents of product defects, adverse reactions, or unforeseen complications can lead to recalls, damaging both company reputations and consumer trust. Such events may result in regulatory scrutiny, legal liabilities, and financial losses for manufacturers. Safety concerns can also slow down the adoption of new technologies as healthcare providers become more cautious. Additionally, negative publicity surrounding these issues can impact the entire industry, potentially slowing market growth.
The COVID-19 pandemic initially disrupted the advanced wound care and closure market, causing supply chain issues and postponement of non-emergency procedures. However, it also highlighted the importance of advanced wound care in preventing complications in COVID-19 patients. The pandemic accelerated the adoption of telehealth solutions for wound care management and emphasized the need for infection control measures in wound treatment protocols. These changes are likely to have lasting effects on market trends and product development.
The dressings segment is expected to be the largest during the forecast period
Over the forecasted timeframe, the dressings segment is anticipated to dominate the market share. This dominance can be attributed to the wide range of dressing types available, including foam dressings, hydrocolloid dressings, alginate dressings, and antimicrobial dressings, each catering to specific wound types and healing stages. The versatility and effectiveness of advanced dressings in managing various wound conditions, from chronic ulcers to surgical wounds, contribute to their widespread use. Additionally, ongoing innovations in dressing materials and designs, such as smart dressings with sensors for wound monitoring, are further driving the segment's growth.
The negative pressure wound therapy (NPWT) segment is expected to have the highest CAGR during the forecast period
During the projection period, the negative pressure wound therapy (NPWT) segment is expected to grow at the highest CAGR. This rapid growth can be attributed to the increasing recognition of NPWT's effectiveness in managing complex and hard-to-heal wounds. NPWT systems promote faster healing by creating a controlled negative pressure environment that removes excess fluid, reduces edema, and stimulates granulation tissue formation. The technology's versatility in treating various wound types, including surgical wounds, pressure ulcers, and diabetic foot ulcers, contributes to its growing adoption.
During the estimation period, the North America region is expected to capture the largest market share. This dominance can be attributed to several factors, including the region's well-established healthcare infrastructure, high healthcare expenditure, and early adoption of advanced medical technologies. The prevalence of chronic diseases such as diabetes and obesity, which often lead to complex wounds, is also higher in North America. The region benefits from a strong presence of key market players, driving innovation and product availability. Additionally, favorable reimbursement policies for advanced wound care products and a growing aging population contribute to the market's size.
The Asia Pacific region is projected to achieve the highest CAGR during the forecast period. This rapid growth can be attributed to several factors, including the region's large and growing population, increasing healthcare expenditure, and improving healthcare infrastructure. The rising prevalence of chronic diseases, coupled with a growing awareness of advanced wound care techniques, is driving market expansion. Governments in countries like China and India are investing heavily in healthcare modernization, creating opportunities for advanced wound care adoption. The region's expanding medical tourism industry also contributes to market growth.
Key players in the market
Some of the key players in Advanced Wound Care and Closure Market include 3M Company, Smith & Nephew plc, ConvaTec Group plc, Coloplast A/S, Molnlycke Health Care AB, B. Braun Melsungen AG, Johnson & Johnson, Medtronic plc, Cardinal Health, Inc., Paul Hartmann AG, Integra LifeSciences Holdings Corporation, Baxter International Inc., Essity AB, Acelity L.P. Inc., Organogenesis Holdings Inc., Hollister Incorporated, MiMedx Group, Inc., and Ethicon, Inc.
In October 2024, Molnlycke Health Care AB acquired P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn wound cleansing and moisturizing solutions, to expand its wound care portfolio.
In April 2024, Smith+Nephew, the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a patient-centric option for treating chronic wounds. The system is lightweight and compact, allowing it to be easily carried or worn. It features a discreet canister and operates quietly so as not to draw attention or disturb the patients' daily activities.
In January 2024, 3M Company received a $34.2 million award from the U.S. Army Medical Research Acquisition Activity to develop new solutions for infection prevention, wound management, and wound healing, focusing on treatment strategies for emergency settings and mass casualty situations.